annual accounts payable:
$15.38M-$2.02M(-11.61%)Summary
- As of today (May 21, 2025), CORT annual accounts payable is $15.38 million, with the most recent change of -$2.02 million (-11.61%) on December 31, 2024.
- During the last 3 years, CORT annual accounts payable has risen by +$8.47 million (+122.58%).
- CORT annual accounts payable is now -11.61% below its all-time high of $17.40 million, reached on December 31, 2023.
Performance
CORT Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$27.95M+$12.57M(+81.76%)Summary
- As of today (May 21, 2025), CORT quarterly accounts payable is $27.95 million, with the most recent change of +$12.57 million (+81.76%) on March 31, 2025.
- Over the past year, CORT quarterly accounts payable has increased by +$15.39 million (+122.56%).
- CORT quarterly accounts payable is now at all-time high.
Performance
CORT quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
CORT Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.6% | +122.6% |
| 3 y3 years | +122.6% | +201.5% |
| 5 y5 years | +104.0% | +461.6% |
CORT Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -11.6% | +122.6% | at high | +250.4% |
| 5 y | 5-year | -11.6% | +122.6% | at high | +461.6% |
| alltime | all time | -11.6% | +2700.7% | at high | >+9999.0% |
CORT Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $27.95M(+81.8%) |
| Dec 2024 | $15.38M(-11.6%) | $15.38M(-17.3%) |
| Sep 2024 | - | $18.58M(-4.6%) |
| Jun 2024 | - | $19.48M(+55.2%) |
| Mar 2024 | - | $12.56M(-27.8%) |
| Dec 2023 | $17.40M(+45.3%) | $17.40M(+4.1%) |
| Sep 2023 | - | $16.71M(+109.5%) |
| Jun 2023 | - | $7.98M(-28.9%) |
| Mar 2023 | - | $11.22M(-6.3%) |
| Dec 2022 | $11.98M(+73.4%) | $11.98M(+46.4%) |
| Sep 2022 | - | $8.18M(-0.8%) |
| Jun 2022 | - | $8.25M(-11.0%) |
| Mar 2022 | - | $9.27M(+34.2%) |
| Dec 2021 | $6.91M(-34.5%) | $6.91M(+5.3%) |
| Sep 2021 | - | $6.56M(-28.8%) |
| Jun 2021 | - | $9.22M(+32.2%) |
| Mar 2021 | - | $6.97M(-34.0%) |
| Dec 2020 | $10.55M(+40.0%) | $10.55M(+62.1%) |
| Sep 2020 | - | $6.51M(+3.3%) |
| Jun 2020 | - | $6.30M(+26.7%) |
| Mar 2020 | - | $4.98M(-34.0%) |
| Dec 2019 | $7.54M(-8.8%) | $7.54M(+26.9%) |
| Sep 2019 | - | $5.94M(-15.5%) |
| Jun 2019 | - | $7.03M(-24.7%) |
| Mar 2019 | - | $9.33M(+12.9%) |
| Dec 2018 | $8.27M(-3.6%) | $8.27M(-40.6%) |
| Sep 2018 | - | $13.92M(+118.7%) |
| Jun 2018 | - | $6.37M(-18.9%) |
| Mar 2018 | - | $7.85M(-8.5%) |
| Dec 2017 | $8.58M(+274.6%) | $8.58M(+37.8%) |
| Sep 2017 | - | $6.23M(+199.0%) |
| Jun 2017 | - | $2.08M(-51.0%) |
| Mar 2017 | - | $4.25M(+85.7%) |
| Dec 2016 | $2.29M(+72.8%) | $2.29M(-46.9%) |
| Sep 2016 | - | $4.31M(+107.1%) |
| Jun 2016 | - | $2.08M(-0.0%) |
| Mar 2016 | - | $2.08M(+57.1%) |
| Dec 2015 | $1.32M(-29.7%) | $1.32M(-23.9%) |
| Sep 2015 | - | $1.74M(-26.3%) |
| Jun 2015 | - | $2.36M(+127.8%) |
| Mar 2015 | - | $1.04M(-45.1%) |
| Dec 2014 | $1.89M | $1.89M(-3.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2014 | - | $1.96M(-24.5%) |
| Jun 2014 | - | $2.60M(-29.2%) |
| Mar 2014 | - | $3.67M(+54.0%) |
| Dec 2013 | $2.38M(-37.4%) | $2.38M(+1.9%) |
| Sep 2013 | - | $2.34M(-22.9%) |
| Jun 2013 | - | $3.03M(+34.0%) |
| Mar 2013 | - | $2.26M(-40.5%) |
| Dec 2012 | $3.80M(+5.3%) | $3.80M(+141.7%) |
| Sep 2012 | - | $1.57M(-62.8%) |
| Jun 2012 | - | $4.24M(+103.2%) |
| Mar 2012 | - | $2.08M(-42.3%) |
| Dec 2011 | $3.61M(+342.0%) | $3.61M(+238.7%) |
| Sep 2011 | - | $1.07M(-53.5%) |
| Jun 2011 | - | $2.29M(+22.8%) |
| Mar 2011 | - | $1.86M(+128.3%) |
| Dec 2010 | $817.00K(-35.7%) | $817.00K(-30.3%) |
| Jun 2010 | - | $1.17M(+14.7%) |
| Mar 2010 | - | $1.02M(-19.4%) |
| Dec 2009 | $1.27M(-2.6%) | $1.27M(+42.4%) |
| Sep 2009 | - | $892.00K(+33.1%) |
| Jun 2009 | - | $670.00K(-57.4%) |
| Mar 2009 | - | $1.57M(+20.5%) |
| Dec 2008 | $1.30M(+17.0%) | $1.30M(+30.0%) |
| Sep 2008 | - | $1.00M(-8.7%) |
| Jun 2008 | - | $1.10M(+25.1%) |
| Mar 2008 | - | $878.00K(-21.3%) |
| Dec 2007 | $1.11M(+21.7%) | $1.11M(-33.1%) |
| Sep 2007 | - | $1.67M(+444.4%) |
| Jun 2007 | - | $306.00K(-62.2%) |
| Mar 2007 | - | $809.00K(-11.7%) |
| Dec 2006 | $916.00K(+66.8%) | $916.00K(-65.0%) |
| Sep 2006 | - | $2.62M(+107.0%) |
| Jun 2006 | - | $1.26M(+2.8%) |
| Mar 2006 | - | $1.23M(+124.2%) |
| Dec 2005 | $549.00K(-0.2%) | $549.00K(-34.1%) |
| Sep 2005 | - | $833.00K(+566.4%) |
| Jun 2005 | - | $125.00K(-56.1%) |
| Mar 2005 | - | $285.00K(-48.2%) |
| Dec 2004 | $550.00K | $550.00K(-43.9%) |
| Sep 2004 | - | $980.50K(+55.7%) |
| Jun 2004 | - | $629.80K(-32.7%) |
| Mar 2004 | - | $935.80K |
FAQ
- What is Corcept Therapeutics Incorporated annual accounts payable?
- What is the all time high annual accounts payable for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated annual accounts payable year-on-year change?
- What is Corcept Therapeutics Incorporated quarterly accounts payable?
- What is the all time high quarterly accounts payable for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated quarterly accounts payable year-on-year change?
What is Corcept Therapeutics Incorporated annual accounts payable?
The current annual accounts payable of CORT is $15.38M
What is the all time high annual accounts payable for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high annual accounts payable is $17.40M
What is Corcept Therapeutics Incorporated annual accounts payable year-on-year change?
Over the past year, CORT annual accounts payable has changed by -$2.02M (-11.61%)
What is Corcept Therapeutics Incorporated quarterly accounts payable?
The current quarterly accounts payable of CORT is $27.95M
What is the all time high quarterly accounts payable for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high quarterly accounts payable is $27.95M
What is Corcept Therapeutics Incorporated quarterly accounts payable year-on-year change?
Over the past year, CORT quarterly accounts payable has changed by +$15.39M (+122.56%)